Literature DB >> 33590857

Exposure to Nicotine and Toxicants Among Dual Users of Tobacco Cigarettes and E-Cigarettes: Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

Danielle M Smith1, Carol Christensen2, Dana van Bemmel2, Nicolette Borek2, Bridget Ambrose2, Gladys Erives2, Raymond Niaura3, Kathryn C Edwards4, Cassandra A Stanton4, Benjamin C Blount5, Lanqing Wang5, Jun Feng5, Jeffery M Jarrett6, Cynthia D Ward6, Dorothy Hatsukami7, Stephen S Hecht7, Heather L Kimmel8, Mark Travers1, Andrew Hyland1, Maciej L Goniewicz1.   

Abstract

INTRODUCTION: Concurrent use of tobacco cigarettes and e-cigarettes ("dual use") is common among tobacco users. Little is known about differences in demographics and toxicant exposure among subsets of dual users. AIMS AND METHODS: We analyzed data from adult dual users (current every/some day users of tobacco cigarettes and e-cigarettes, n = 792) included in the PATH Study Wave 1 (2013-2014) and provided urine samples. Samples were analyzed for biomarkers of exposure to nicotine and selected toxicants (tobacco-specific nitrosamine NNK [NNAL], lead, cadmium, naphthalene [2-naphthol], pyrene [1-hydroxypyrene], acrylonitrile [CYMA], acrolein [CEMA], and acrylamide [AAMA]). Subsets of dual users were compared on demographic, behavioral, and biomarker measures to exclusive cigarette smokers (n = 2411) and exclusive e-cigarette users (n = 247).
RESULTS: Most dual users were predominant cigarette smokers (70%), followed by daily dual users (13%), non-daily concurrent dual users (10%), and predominant vapers (7%). Dual users who smoked daily showed significantly higher biomarker concentrations compared with those who did not smoke daily. Patterns of e-cigarette use had little effect on toxicant exposure. Dual users with high toxicant exposure were generally older, female, and smoked more cigarettes per day. Dual users who had low levels of biomarkers of exposure were generally younger, male, and smoked non-daily.
CONCLUSIONS: In 2013-2014, most dual users smoked cigarettes daily and used e-cigarettes occasionally. Cigarette smoking appears to be the primary driver of toxicant exposure among dual users, with little-to-no effect of e-cigarette use on biomarker levels. Results reinforce the need for dual users to stop smoking tobacco cigarettes to reduce toxicant exposure. IMPLICATIONS: With considerable dual use of tobacco cigarettes and e-cigarettes in the United States, it is important to understand differences in toxicant exposure among subsets of dual users, and how these differences align with user demographics. Findings suggest most dual users smoke daily and use e-cigarettes intermittently. Low exposure to toxicants was most common among younger users, males, and intermittent smokers; high exposure to toxicants was most common among older users, females, and heavier cigarette smokers. Results underscore the heterogeneity occurring within dual users, and the need to quit smoking cigarettes completely in order to reduce toxicant exposure.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33590857      PMCID: PMC8095240          DOI: 10.1093/ntr/ntaa252

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  30 in total

1.  Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers.

Authors:  G D Byrd; K M Chang; J M Greene; J D deBethizy
Journal:  Drug Metab Dispos       Date:  1992 Mar-Apr       Impact factor: 3.922

2.  Quantitative analysis of five tobacco-specific N-nitrosamines in urine by liquid chromatography-atmospheric pressure ionization tandem mass spectrometry.

Authors:  Baoyun Xia; Yang Xia; Joshua Wong; Keegan J Nicodemus; Meng Xu; John Lee; Tonya Guillot; James Li
Journal:  Biomed Chromatogr       Date:  2013-10-11       Impact factor: 1.902

3.  Are Some E-Cigarette Users "Blowing Smoke"?: Assessing the Accuracy of Self-Reported Smoking Abstinence in Exclusive E-Cigarette Users.

Authors:  Maciej L Goniewicz; Danielle M Smith
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

4.  Measuring urinary N-acetyl-S-(4-hydroxy-2-methyl-2-buten-1-yl)-L-cysteine (IPMA3) as a potential biomarker of isoprene exposure.

Authors:  K Udeni Alwis; T Liz Bailey; Dhrusti Patel; Liqun Wang; Benjamin C Blount
Journal:  Anal Chim Acta       Date:  2016-08-21       Impact factor: 6.558

5.  A new classification system for describing concurrent use of nicotine vaping products alongside cigarettes (so-called 'dual use'): findings from the ITC-4 Country Smoking and Vaping wave 1 Survey.

Authors:  Ron Borland; Krista Murray; Shannon Gravely; Geoffrey T Fong; Mary E Thompson; Ann McNeill; Richard J O'Connor; Maciej L Goniewicz; Hua-Hie Yong; David T Levy; Bryan W Heckman; K Michael Cummings
Journal:  Addiction       Date:  2019-04-02       Impact factor: 6.526

6.  Nicotine Replacement, Topography, and Smoking Phenotypes of E-cigarettes.

Authors:  Andrew A Strasser; Valentina Souprountchouk; Amanda Kaufmann; Sonja Blazekovic; Frank Leone; Neal L Benowitz; Robert A Schnoll
Journal:  Tob Regul Sci       Date:  2016-10

7.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

8.  Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Andrew Hyland; Bridget K Ambrose; Kevin P Conway; Nicolette Borek; Elizabeth Lambert; Charles Carusi; Kristie Taylor; Scott Crosse; Geoffrey T Fong; K Michael Cummings; David Abrams; John P Pierce; James Sargent; Karen Messer; Maansi Bansal-Travers; Ray Niaura; Donna Vallone; David Hammond; Nahla Hilmi; Jonathan Kwan; Andrea Piesse; Graham Kalton; Sharon Lohr; Nick Pharris-Ciurej; Victoria Castleman; Victoria R Green; Greta Tessman; Annette Kaufman; Charles Lawrence; Dana M van Bemmel; Heather L Kimmel; Ben Blount; Ling Yang; Barbara O'Brien; Cindy Tworek; Derek Alberding; Lynn C Hull; Yu-Ching Cheng; David Maklan; Cathy L Backinger; Wilson M Compton
Journal:  Tob Control       Date:  2016-08-08       Impact factor: 7.552

9.  Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study.

Authors:  Lion Shahab; Maciej L Goniewicz; Benjamin C Blount; Jamie Brown; Ann McNeill; K Udeni Alwis; June Feng; Lanqing Wang; Robert West
Journal:  Ann Intern Med       Date:  2017-02-07       Impact factor: 25.391

10.  Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes.

Authors:  Carl D D'Ruiz; Donald W Graff; Edward Robinson
Journal:  BMC Public Health       Date:  2016-07-11       Impact factor: 3.295

View more
  3 in total

1.  Minor Tobacco Alkaloids as Biomarkers to Distinguish Combusted Tobacco Use From Electronic Nicotine Delivery Systems Use. Two New Analytical Methods.

Authors:  Peyton Jacob; Lawrence Chan; Polly Cheung; Kristina Bello; Lisa Yu; Gideon StHelen; Neal L Benowitz
Journal:  Front Chem       Date:  2022-06-01       Impact factor: 5.545

2.  Understanding heterogeneity among individuals who smoke cigarettes and vape: assessment of biomarkers of exposure and potential harm among subpopulations from the PATH Wave 1 Data.

Authors:  Pavel N Lizhnyak; Brendan Noggle; Lai Wei; Jeffery Edmiston; Elizabeth Becker; Ryan A Black; Mohamadi Sarkar
Journal:  Harm Reduct J       Date:  2022-08-17

3.  Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers.

Authors:  Gal Cohen; Nicholas I Goldenson; Patrick C Bailey; Stephanie Chan; Saul Shiffman
Journal:  Nicotine Tob Res       Date:  2021-11-05       Impact factor: 4.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.